36 reports

Acne can significantly impact patients' quality of life, resulting in social, psychological and emotional impairments that are comparable to those reported by patients with epilepsy, asthma, diabetes or arthritis.

  • Dermatology
  • Market Size
  • Actavis plc
  • Allergan plc
  • Foamix Ltd.
  • 9.10 COMPETITIVE ANALYSIS IN ATOPIC DERMATITIS MARKET

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Dermatology
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, REVENUE FORECAST FOR COSENTYX ($BN),
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, APPROVED DERMATOLOGY INDICATIONS FOR

The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma.

  • Dermatology
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.

Current Allergy and Asthma Reports; ##(##): ##-## Reviews; ##(##): ##-## ##: ##-## ##. ## Figures of All Pipeline Products A full version of the below figures, containing all pipeline products, is available in the Excel data download of all tables and figures.

  • Dermatology
  • World
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting CCL11, 2017
  • Dermatology Therapeutics Market, Global, Pipeline Programs Targeting Voltage-Gated Channel Subfamily A Member 3, 2017

Allergy, Asthma & Clinical Immunology. ##(##): ## Coondoo A, et al. (2014).

  • Dermatology
  • World
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, REVENUE FORECAST FOR IXEKIZUMAB

SkyePharma Plc SKP-## Small Molecule ## for Asthma, Diabetes and Inflammatory Skin Disease Small Molecule ## for Asthma, Diabetes and Inflammatory Skin Disease Small Molecule for Acne and Skin Inflammation Small Molecule for Androgenic Alopecia Small Molecule for

  • Dermatology
  • World
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • 5.2 ABBREVIATIONS

Omalizumab beyond asthma.

  • Dermatology
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • GlobalData's company
  • Regeneron Pharmaceuticals, Inc.

Acne Vulgaris - Overview Acne Vulgaris - Therapeutics Development FIGURE ##: NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ACNE VULGARIS, H## 2018 PIPELINE OVERVIEW TABLE ##: NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR ACNE VULGARIS, H## 2018 FIGURE ##: NUMBER OF PRODUCTS UNDER DEVELOPMENT BY C

  • Dermatology
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • Clinical Trial profile. 643 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • World
  • Novartis AG
  • Clinical Trial profile. 813 Trial Title
  • Official Title

Olavs Hospital ## Sep 2003 ## Sep 2007 ## ## ## ## ## Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Biomarker(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s) Sponsor(s) Collaborator(s) Estimated Start Date

  • Clinical Trial
  • Dermatological Condition
  • Dermatology
  • World
  • Novartis AG

It is also developing new approaches to the treatment of asthma.

  • Dermatology
  • Spain
  • United States
  • Company Financials
  • Almirall, S.A.
  • Target
  • Clinical Trial profile. 570 Trial Title

Overview of the study ## patients were randomized to one of the four nemolizumab dose groups (##. ##, ##. ##, ##. ## mg/ kg every ## week (Q##W) or ##. ## mg/ kg every ## week) or placebo group (Q##W) in the ratio of ##:##:##:##:##.

  • Dermatological Condition
  • Dermatology
  • Therapy
  • World
  • Novartis AG

One share of common stock is being sold together with ##. ## of a warrant.

  • Dermatology
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Oculus Innovative Sciences, Inc.

It is also developing new approaches to the treatment of asthma.

  • Dermatology
  • Canada
  • United States
  • M&A
  • Valeant Pharmaceuticals International, Inc.

It is also developing new approaches to the treatment of asthma.

  • Dermatology
  • Canada
  • United States
  • M&A
  • Valeant Pharmaceuticals International, Inc.

Similarly the trials with different status compile of Completed - ##, Ongoing - ##, Planned - ## and Terminated - ##.

  • Dermatological Condition
  • Dermatology
  • Therapy
  • World
  • Product Initiative

In addition, Vectura will also receive one-off undisclosed sales milestones should net sales of both the asthma and COPD products achieve certain predetermined levels.

  • Dermatology
  • Endocrine Disease
  • World
  • Company
  • Deals & Alliance
  • Target

In addition to AD, Dupixent is being evaluated in asthma, nasal polyposis and eosinophilic esophagitis.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

The prominent features of this report are - ##.

  • Dermatological Condition
  • Dermatology
  • Therapy
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Allergy Drug
  • Dermatology
  • World
  • Product Initiative
  • UCB S.A.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Menarini Industrie Farmaceutiche Riunite Srl ## Jan 2017 ## Jul 2017 ## ## ##.

  • Antifungal
  • Dermatology
  • World
  • Product Initiative
  • Aclaris Therapeutics, Inc.

The prominent features of this report are - ##.

  • Dermatology
  • Targeted Therapy
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.

The prominent features of this report are - ##.

  • Acne Treatment
  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Acne Treatment
  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Dermatological Condition
  • Dermatology
  • Therapy
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Services GmbH Source: GlobalData' s Pharma Intel

  • Autoimmune Disease
  • Clinical Trial
  • Dermatology
  • Therapy
  • F. Hoffmann-La Roche Ltd.

Its product pipeline comprises Dupilumab for atopic dermatitis and asthma Patisiran for familial amyloid polyneuropathyIsatuximab for multiple myeloma and Fitisuran for Hemophilia, among others.

  • Clinical Trial
  • Dermatology
  • Prosthesis
  • Therapy
  • Allergan plc

Sandoz Generic Advair Diskus®regulatory submission was accepted by FDA for treatment of asthma and airflow obstruction and reducing exacerbations in patients with COPD.

  • Clinical Trial
  • Dermatology
  • Diagnostics
  • United States
  • GlobalData's company

The prominent features of this report are - ##.

  • Clinical Trial
  • Dermatology
  • Pharmaceutical
  • World
  • Product Initiative

It was demonstrated that beta-glucans could protect against development of asthma in an animal model.

  • Dermatology
  • Healthcare
  • Wound Care
  • United States
  • Product Initiative